Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Apr 2026 for Celularity Inc. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
John R. Haines: trading record in brief
All filings by John R. Haines on record concern Celularity Inc, in the capacity of senior executive. The record holds 9 filings, for trades running from 13 April 2022 to 13 April 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 15 April 2026, the filings show an option exercise in Celularity Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John R. Haines
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
1,641 shares0Class A Common StockSEC:0001493152-26-016833:0
1,641 shares0Class A Common StockSEC:0001641172-25-004822:0
577 shares@ US$1.642.4% of flowClass A Common StockSEC:0001641172-25-004822:1
20,000 shares0Class A Common StockSEC:0001493152-25-007596:0
576 shares@ US$4.116.3% of flowClass A Common StockSEC:0001493152-24-014946:0
70,350 shares@ US$0.43480.7% of flowClass A Common StockSEC:0001493152-24-007475:0
5,770 shares@ US$0.714110.6% of flowClass A Common StockSEC:0000899243-23-011339:0
400,000 sharesClass A Common StockSEC:0000899243-23-005921:0
65,617 sharesClass A Common StockSEC:0000899243-22-015913:0
9 of 9 declarations
